Login

Kuvera co-founder Neelabh Sanyal invests 80% of his portfolio in equities through index funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Fearless Films: Empowering Regional Filmmakers with Feros Care
00:00:00
hVIVO secures fresh contract to round out "wonderful" year - Yamin ‘Mo’ Khan, Chief Executive Officer, Hvivo PLC
00:10:00
The firm values operating experience and action|David Moskowitz,Partner,8VC's Bio-IT
00:10:00
Employee 1st Impact: Insights from H&E Equipment Services CEO | Bradley W. Barber - Chief Executive Officer and Director of H&E Equipment Services, Inc.
00:00:00
Tissue Regenix Group "has the opportunity to become a global commercial organisation" - Danny Lee, CEO, Tissue Regenix Group
00:10:00
Hakan Bulgurlu: Leading Sustainability at Arçelik | Hakan Bulgurlu, CEO, Arçelik AS.
00:10:00
Paul West-Sells on Western Copper and Gold's Casino Project Development in Yukon
00:10:00
Alexandre Ostrowiecki Discusses His Journey, Challenges, and Ambitions for Multi's Future | Alexandre Ostrowiecki ,CEO, Multilaser Industrial SA.
00:10:00
Private Equity's Strategic Moves in European Financial Sector | Steve Pierson, President , Lovell Minnick Partners .
00:10:00
All Things Web and Excitement Around The Metaverse|David Goldberg,General Partner,Alpaca VC
00:10:00
Nathan Lead, Senior Analyst at Morgans, reviews Atlas Arteria as a new addition to Morgans Best Ideas (November 2021).|Graeme Bevans is an Executive Director of ATLAX
00:10:00
Goh Peng Ooi on Game Theory and the Mathematical Solutions for Global Challenges | Goh Peng Ooi , Founder, Silverlake Axis Ltd.

© 2017 - Neuhu+